Formidable Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-85
Closed -$6K 224
2016
Q1
$6K Hold
85
﹤0.01% 388
2015
Q4
$5K Hold
85
﹤0.01% 451
2015
Q3
$5K Hold
85
﹤0.01% 495
2015
Q2
$6K Hold
85
﹤0.01% 420
2015
Q1
$6K Hold
85
﹤0.01% 409
2014
Q4
$6K Hold
85
﹤0.01% 385
2014
Q3
$5K Hold
85
﹤0.01% 392
2014
Q2
$5K Hold
85
﹤0.01% 425
2014
Q1
$5K Hold
85
﹤0.01% 383
2013
Q4
$4K Hold
85
﹤0.01% 423
2013
Q3
$5K Buy
+85
New +$5.09K ﹤0.01% 357

Other funds holding DGX

Formidable Asset Management's DGX Position: Q2 2016 in Review

Formidable Asset Management sold out of Quest Diagnostics (DGX) in Q2 2016, closing a stake of 85 shares — an estimated $6K sold.

Formidable Asset Management first reported a position in DGX in Q3 2013 and held it in 11 quarters. The position peaked at $6K in Q1 2016. 558 funds tracked by Wall St. Rank hold DGX as of Q2 2016.

  • Formidable Asset Management reported no remaining Quest Diagnostics position as of Q2 2016 after selling out during the quarter.
  • Formidable Asset Management sold 85 Quest Diagnostics shares in Q2 2016, an estimated $6K.
  • Formidable Asset Management first reported a position in Quest Diagnostics in Q3 2013 and held it in 11 quarters.
  • Formidable Asset Management's Quest Diagnostics position peaked at $6K in Q1 2016.
  • 558 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2016.

Based on Formidable Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.